CIK 0001534248
- Non-accelerated filer
- Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- EIN
- 813676773
- Phone
- +972 773310156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,516
- in 1 filing
Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Fatal Sigal Chief Financial Officer | Grant or award · Option to Purchase American Depositary Shares | +102,860 | 167,860 | ||
| 2022-11-08 | Fatal Sigal Chief Financial Officer | Grant or award · Option to Purchase American Depositary Shares | +29,400 | 65,000 | ||
| 2021-11-11 | Fatal Sigal Chief Financial Officer | Grant or award · Option to Purchase American Depositary Shares | +35,600 | 35,600 | ||
| 2021-05-07 | Fatal Sigal Chief Financial Officer | Grant or award · Option to Purchase American Depositary Shares | +35,653 | 35,653 |
Page 1 of 1 · 4 trades